Guideline Recommendations for Testing of ALK Gene Rearrangement in Lung Cancer: A Proposal of the Korean Cardiopulmonary Pathology Study Group

Rearrangement of anaplastic lymphoma kinase (ALK) gene is the best predictor of response to crizotinib, an ALK tyrosine kinase inhibitor. However, the prevalence of the ALK fusion is low, so accurate patient identification is crucial for successful treatment using ALK inhibitors. Furthermore, most p...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kim, Hyojin, Shim, Hyo Sup, Kim, Lucia, Kim, Tae-Jung, Kwon, Kun Young, Lee, Geon Kook, Chung, Jin-Haeng
Formato: Artigo
Idioma:Inglês
Publicado: The Korean Society of Pathologists and The Korean Society for Cytopathology 2014
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3950228/
https://ncbi.nlm.nih.gov/pubmed/24627688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.1
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares